Hoboken University Medical Center | |
308 Willow Ave, Hoboken, New Jersey 07030 | |
(201) 418-1000 | |
Name | Hoboken University Medical Center |
---|---|
Type | Acute Care Hospital |
Location | 308 Willow Ave, Hoboken, New Jersey |
Ownership | Voluntary non-profit - Church |
Emergency Services | Yes |
Medicare ID (CCN) | 310040 |
NPI Number | 1043475668 |
Organization Name | HUMC OPCO LLC |
Address | 308 Willow Ave, Hoboken, NJ 07030 |
Hospital Type | General Acute Care Hospital |
Phone Number | 201-418-1000 |
News Archive
New research which has identified 20 sections of genetic code linked to height may also lead to new treatments for arthritis and cancer.
A team of researchers from the University of California San Francisco has created a powerful nasal spray or inhaler that can provide high-grade protection against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The report is presently available on the bioRvix* preprint server.
The i-gel supraglottic airway device provides reliable ventilation in patients under anesthesia, results of a prospective multicentre observational study show.
Allergan plc, a leading global pharmaceutical company, today announced that its wholly owned subsidiary has entered into an exclusive licensing agreement with Mimetogen Pharmaceuticals, a clinical stage biotechnology company, to develop and commercialize tavilermide (MIM-D3), a topical formulation of a novel small molecule TrkA agonist for the treatment of dry eye disease.
› Verified 6 days ago
NPI Number | 1326125147 |
Organization Name | HOBOKEN MUNICIPAL HOSPITAL |
Address | 308 Willow Ave, Hoboken, NJ 07030 |
Hospital Type | General Acute Care Hospital |
Phone Number | 201-418-2184 |
News Archive
New research which has identified 20 sections of genetic code linked to height may also lead to new treatments for arthritis and cancer.
A team of researchers from the University of California San Francisco has created a powerful nasal spray or inhaler that can provide high-grade protection against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The report is presently available on the bioRvix* preprint server.
The i-gel supraglottic airway device provides reliable ventilation in patients under anesthesia, results of a prospective multicentre observational study show.
Allergan plc, a leading global pharmaceutical company, today announced that its wholly owned subsidiary has entered into an exclusive licensing agreement with Mimetogen Pharmaceuticals, a clinical stage biotechnology company, to develop and commercialize tavilermide (MIM-D3), a topical formulation of a novel small molecule TrkA agonist for the treatment of dry eye disease.
› Verified 6 days ago
Able to receive lab results electronically | Yes |
Able to track patients' lab results, tests, and referrals electronically between visits | Yes |
News Archive
New research which has identified 20 sections of genetic code linked to height may also lead to new treatments for arthritis and cancer.
A team of researchers from the University of California San Francisco has created a powerful nasal spray or inhaler that can provide high-grade protection against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The report is presently available on the bioRvix* preprint server.
The i-gel supraglottic airway device provides reliable ventilation in patients under anesthesia, results of a prospective multicentre observational study show.
Allergan plc, a leading global pharmaceutical company, today announced that its wholly owned subsidiary has entered into an exclusive licensing agreement with Mimetogen Pharmaceuticals, a clinical stage biotechnology company, to develop and commercialize tavilermide (MIM-D3), a topical formulation of a novel small molecule TrkA agonist for the treatment of dry eye disease.
› Verified 6 days ago
Hoboken University Medical Center Acute Care Hospital Location: 308 Willow Ave, Hoboken, New Jersey 07030 Phone: (201) 418-1000 |